The field of neurogenetics is dedicated to understanding the role of genetics in the development and progression of neurological disorders. Researchers are uncovering how mutations in specific genes lead to a wide range of conditions, from rare inherited diseases to more common neurological disorders like multiple sclerosis and Parkinson’s disease. The use of advanced technologies, such as genome-wide association studies (GWAS), is helping to identify new genetic variants associated with neurological diseases, offering insights into their underlying causes. Furthermore, the advent of gene therapy and genome editing techniques is providing new hope for treating genetic neurological conditions by correcting or replacing faulty genes. The study of epigenetics also plays a vital role in understanding how environmental factors influence genetic expression in the brain.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany